Latest Retail Entitlement Offer News

NEXTDC has successfully closed the retail segment of its fully underwritten entitlement offer, securing A$480 million at A$12.70 per share. The total raise of approximately A$1.5 billion demonstrates strong investor backing ahead of the shares commencing trade on 19 May 2026.

Tamboran Resources has reported record gas flow rates from its Shenandoah South 6H well and secured US$188 million in a capital raise, positioning the company to deliver first gas in the Beetaloo Basin by Q3 2026.

BWP Group has launched the retail tranche of its fully underwritten $228 million entitlement offer at $3.77 per security, aiming to fund a $163 million development pipeline and reduce gearing.

Navigator Global Investments (ASX: NGI) has kicked off a fully underwritten entitlement offer to raise A$145 million, supporting its US$195 million acquisition of a portfolio of alternative asset manager stakes from Stable Asset Management.

Murray Cod Australia (ASX:MCA) has launched the retail tranche of its fully underwritten $18.6 million entitlement offer at a 43% discount, aiming to convert its record 3,700-tonne biomass into cash and expand processing capacity.

BWP Property Group has announced a fully underwritten $228 million entitlement offer to finance a $163 million development pipeline, primarily focused on large format retail assets, reaffirming its FY26 distribution guidance.

NEXTDC urges eligible retail shareholders to participate in its A$1.5 billion entitlement offer, priced at a 10.9% discount, with a top-up facility available. The retail offer closes on 11 May 2026, following recent senior debt commitments that bolster its growth plans.

Eagers Automotive has finalized its majority acquisition of CanadaOne Auto, positioning itself among the world’s largest automotive retail groups with combined pro-forma revenue nearing A$19 billion.

Tamboran Resources has closed its retail entitlement offer, adding A$24.8 million to a total equity raise of A$282.6 million to fund expanded drilling and development in the Beetaloo Basin.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

PYC Therapeutics has gained Orphan Drug Designation from the European Medicines Agency for its VP-001 candidate targeting Retinitis Pigmentosa type 11, enhancing its regulatory and commercial pathway in Europe.